HeartSciences (HSCS) Stock: Buy, Sell, or Hold?
HSCS - HeartSciences Inc. Common Stock
$3.56
0.43 (13.74%)
▲
5d:
+17.88%
30d:
-22.78%
90d:
+45.9%
HOLD
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Sep 10, 2026
0d
Get Alerted When HSCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HSCS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: HSCS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: HSCS is currently trading at $3.56, which is considered fair relative to its 30-day fair value range of $3.20 to $4.52.
Technical Outlook: Technically, HSCS is in a strong uptrend. Immediate support is located at $2.89, while resistance sits at $3.68. The stock is showing strong short-term momentum, up 13.7% recently.
Market Sentiment: HSCS scores 86/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.00 (+237.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HSCS is in a strong uptrend. Immediate support is located at $2.89, while resistance sits at $3.68. The stock is showing strong short-term momentum, up 13.7% recently.
Market Sentiment: HSCS scores 86/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.00 (+237.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.20 -
$4.52
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (86/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+13.7%)
- BULLISH: Trading 237.1% below Wall St target ($12.00)
- CAUTION: Bottoming setup, but lagging the sector by 14% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$3.20 -
$4.52
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.89
Resistance Level
$3.68
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.26
Wall Street Target
$12.00
(+237.1%)
Revenue Growth (YoY)
10.5%
Share & Embed Analysis
Last updated: October 21, 2026 11:23 PM ET
Data refreshes hourly during market hours. Next update: 12:23 AM
Data refreshes hourly during market hours. Next update: 12:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSCS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 75 BUY |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 54 HOLD |
